VERACYTE, INC. Increase (Decrease) in Accounts Receivable
VERACYTE, INC. (VCYT) reported Increase (Decrease) in Accounts Receivable of $9.73 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-31.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2026-07-31
- VERACYTE, INC. increase (decrease) in accounts receivable for the quarter ending 2026-06-30 was $4.16M.
- VERACYTE, INC. increase (decrease) in accounts receivable for the quarter ending 2026-03-31 was $5.57M, a 21.07% decline year-over-year.
- VERACYTE, INC. increase (decrease) in accounts receivable for the quarter ending 2025-12-31 was -$3.15M.
- VERACYTE, INC. increase (decrease) in accounts receivable for the quarter ending 2025-09-30 was -$425.00K.
- VERACYTE, INC. increase (decrease) in accounts receivable for fiscal 2025 was $708.00K, a 88.95% decline from fiscal 2024.
- VERACYTE, INC. increase (decrease) in accounts receivable for fiscal 2024 was $6.41M.
- VERACYTE, INC. increase (decrease) in accounts receivable for fiscal 2023 was -$3.89M, a 186.47% decline from fiscal 2022.
- VERACYTE, INC. increase (decrease) in accounts receivable for fiscal 2022 was $4.50M, a 47.56% decline from fiscal 2021.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 12 month |
|---|---|---|---|---|
| 2026-06-30 | $4.16M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-31 | $9.73M 10-Q · filed 2026-07-31 | $6.58M derived: sum of 3 quarters · filed 2026-07-31 | $6.15M derived: sum of 4 quarters · filed 2026-07-31 |
| 2026-03-31 | $5.57M 10-Q · filed 2026-05-06 | $2.42M derived: sum of 2 quarters · filed 2026-05-06 | $1.99M derived: sum of 3 quarters · filed 2026-05-06 | -$778.00K derived: sum of 4 quarters · filed 2026-07-31 |
| 2025-12-31 | -$3.15M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$3.58M derived: sum of 2 quarters · filed 2026-02-26 | -$6.34M derived: sum of 3 quarters · filed 2026-07-31 | $708.00K 10-K · filed 2026-02-26 |
| 2025-09-30 | -$425.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$3.19M derived: sum of 2 quarters · filed 2026-07-31 | $3.86M 10-Q · filed 2025-11-05 | $1.87M derived: sum of 4 quarters · filed 2026-07-31 |
| 2025-06-30 | -$2.77M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-31 | $4.28M 10-Q · filed 2026-07-31 | $2.29M derived: sum of 3 quarters · filed 2026-07-31 | $602.00K derived: sum of 4 quarters · filed 2026-07-31 |
| 2025-03-31 | $7.05M 10-Q · filed 2026-05-06 | $5.06M derived: sum of 2 quarters · filed 2026-05-06 | $3.37M derived: sum of 3 quarters · filed 2026-05-06 | $7.00M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | -$1.99M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$3.68M derived: sum of 2 quarters · filed 2026-02-26 | -$54.00K derived: sum of 3 quarters · filed 2026-02-26 | $6.41M 10-K · filed 2026-02-26 |
| 2024-09-30 | -$1.69M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $1.94M derived: sum of 2 quarters · filed 2025-11-05 | $8.40M 10-Q · filed 2025-11-05 | $9.16M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $3.63M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $10.09M 10-Q · filed 2025-08-07 | $10.85M derived: sum of 3 quarters · filed 2026-02-26 | $7.99M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $6.46M 10-Q · filed 2025-05-08 | $7.22M derived: sum of 2 quarters · filed 2026-02-26 | $4.36M derived: sum of 3 quarters · filed 2026-02-26 | $1.27M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $763.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$2.10M derived: sum of 2 quarters · filed 2026-02-26 | -$5.19M derived: sum of 3 quarters · filed 2026-02-26 | -$3.89M 10-K · filed 2026-02-26 |
| 2023-09-30 | -$2.86M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | -$5.95M derived: sum of 2 quarters · filed 2024-11-07 | -$4.65M 10-Q · filed 2024-11-07 | -$4.51M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-06-30 | -$3.09M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | -$1.79M 10-Q · filed 2024-08-07 | -$1.65M derived: sum of 3 quarters · filed 2025-02-28 | -$230.00K derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-03-31 | $1.30M 10-Q · filed 2024-05-08 | $1.44M derived: sum of 2 quarters · filed 2025-02-28 | $2.86M derived: sum of 3 quarters · filed 2025-02-28 | $2.22M derived: sum of 4 quarters · filed 2025-02-28 |
| 2022-12-31 | $139.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $1.56M derived: sum of 2 quarters · filed 2025-02-28 | $920.00K derived: sum of 3 quarters · filed 2025-02-28 | $4.50M 10-K · filed 2025-02-28 |
| 2022-09-30 | $1.42M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $781.00K derived: sum of 2 quarters · filed 2023-11-08 | $4.36M 10-Q · filed 2023-11-08 | $6.64M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-06-30 | -$639.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $2.94M 10-Q · filed 2023-08-09 | $5.22M derived: sum of 3 quarters · filed 2024-02-29 | $4.79M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-03-31 | $3.58M 10-Q · filed 2023-05-05 | $5.86M derived: sum of 2 quarters · filed 2024-02-29 | $5.43M derived: sum of 3 quarters · filed 2024-02-29 | $8.40M derived: sum of 4 quarters · filed 2024-02-29 |
| 2021-12-31 | $2.29M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $1.86M derived: sum of 2 quarters · filed 2024-02-29 | $4.82M derived: sum of 3 quarters · filed 2024-02-29 | $8.57M 10-K · filed 2024-02-29 |
| 2021-09-30 | -$428.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $2.54M derived: sum of 2 quarters · filed 2022-11-03 | $6.29M 10-Q · filed 2022-11-03 | $7.07M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-06-30 | $2.96M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | $6.71M 10-Q · filed 2022-08-03 | $7.50M derived: sum of 3 quarters · filed 2023-03-01 | $9.78M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-03-31 | $3.75M 10-Q · filed 2022-05-04 | $4.54M derived: sum of 2 quarters · filed 2023-03-01 | $6.82M derived: sum of 3 quarters · filed 2023-03-01 | $3.03M derived: sum of 4 quarters · filed 2023-03-01 |
| 2020-12-31 | $787.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $3.07M derived: sum of 2 quarters · filed 2023-03-01 | -$717.00K derived: sum of 3 quarters · filed 2023-03-01 | -$955.00K 10-K · filed 2023-03-01 |
| 2020-09-30 | $2.28M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | -$1.50M derived: sum of 2 quarters · filed 2021-11-09 | -$1.74M 10-Q · filed 2021-11-09 | -$6.03M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-06-30 | -$3.79M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-29 | -$4.02M 10-Q · filed 2021-07-29 | -$8.31M derived: sum of 3 quarters · filed 2022-02-28 | -$4.32M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-03-31 | -$238.00K 10-Q · filed 2021-05-10 | -$4.52M derived: sum of 2 quarters · filed 2022-02-28 | -$535.00K derived: sum of 3 quarters · filed 2022-02-28 | $2.48M derived: sum of 4 quarters · filed 2022-02-28 |
| 2019-12-31 | -$4.28M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | -$297.00K derived: sum of 2 quarters · filed 2022-02-28 | $2.71M derived: sum of 3 quarters · filed 2022-02-28 | $6.16M 10-K · filed 2022-02-28 |
| 2019-09-30 | $3.99M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-02 | $7.00M derived: sum of 2 quarters · filed 2020-11-02 | $10.45M 10-Q · filed 2020-11-02 | $11.35M derived: sum of 4 quarters · filed 2021-02-22 |
| 2019-06-30 | $3.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-30 | $6.46M 10-Q · filed 2020-07-30 | $7.36M derived: sum of 3 quarters · filed 2021-02-22 | $6.62M derived: sum of 4 quarters · filed 2021-02-22 |
| 2019-03-31 | $3.45M 10-Q · filed 2020-05-06 | $4.35M derived: sum of 2 quarters · filed 2021-02-22 | $3.61M derived: sum of 3 quarters · filed 2021-02-22 | $3.42M derived: sum of 4 quarters · filed 2021-02-22 |
| 2018-12-31 | $906.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-22 | $162.00K derived: sum of 2 quarters · filed 2021-02-22 | -$30.00K derived: sum of 3 quarters · filed 2021-02-22 | $452.00K 10-K · filed 2021-02-22 |
| 2018-09-30 | -$744.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-22 | -$936.00K derived: sum of 2 quarters · filed 2019-10-22 | -$454.00K 10-Q · filed 2019-10-22 | $627.00K derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-06-30 | -$192.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-30 | $290.00K 10-Q · filed 2019-07-30 | $1.37M derived: sum of 3 quarters · filed 2020-02-25 | $1.98M derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-03-31 | $482.00K 10-Q · filed 2019-04-30 | $1.56M derived: sum of 2 quarters · filed 2020-02-25 | $2.17M derived: sum of 3 quarters · filed 2020-02-25 | $4.07M derived: sum of 4 quarters · filed 2020-02-25 |
| 2017-12-31 | $1.08M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $1.69M derived: sum of 2 quarters · filed 2020-02-25 | $3.59M derived: sum of 3 quarters · filed 2020-02-25 | $3.96M 10-K · filed 2020-02-25 |
| 2017-09-30 | $608.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-29 | $2.51M derived: sum of 2 quarters · filed 2018-10-29 | $2.88M 10-Q · filed 2018-10-29 | $5.32M derived: sum of 4 quarters · filed 2019-02-25 |
| 2017-06-30 | $1.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-23 | $2.27M 10-Q · filed 2018-07-23 | $4.71M derived: sum of 3 quarters · filed 2019-02-25 | $7.64M derived: sum of 4 quarters · filed 2019-02-25 |
| 2017-03-31 | $369.00K 10-Q · filed 2018-05-01 | $2.81M derived: sum of 2 quarters · filed 2019-02-25 | $5.74M derived: sum of 3 quarters · filed 2019-02-25 | $5.90M derived: sum of 4 quarters · filed 2019-02-25 |
| 2016-12-31 | $2.44M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-25 | $5.37M derived: sum of 2 quarters · filed 2019-02-25 | $5.53M derived: sum of 3 quarters · filed 2019-02-25 | $5.32M 10-K · filed 2019-02-25 |
| 2016-09-30 | $2.92M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $3.08M derived: sum of 2 quarters · filed 2017-11-07 | $2.88M 10-Q · filed 2017-11-07 | $2.88M derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-06-30 | $159.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-31 | -$48.00K 10-Q · filed 2017-07-31 | -$40.00K derived: sum of 3 quarters · filed 2018-02-27 | -$79.00K derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-03-31 | -$207.00K 10-Q · filed 2017-05-03 | -$199.00K derived: sum of 2 quarters · filed 2018-02-27 | -$238.00K derived: sum of 3 quarters · filed 2018-02-27 | $817.00K derived: sum of 4 quarters · filed 2018-02-27 |
| 2015-12-31 | $8.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | -$31.00K derived: sum of 2 quarters · filed 2018-02-27 | $1.02M derived: sum of 3 quarters · filed 2018-02-27 | $558.00K 10-K · filed 2018-02-27 |
| 2015-09-30 | -$39.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | $1.02M derived: sum of 2 quarters · filed 2016-11-03 | $550.00K 10-Q · filed 2016-11-03 | $2.41M derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-06-30 | $1.05M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-03 | $589.00K 10-Q · filed 2016-08-03 | $2.45M derived: sum of 3 quarters · filed 2017-03-01 | $2.22M derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-03-31 | -$466.00K 10-Q · filed 2016-05-05 | $1.39M derived: sum of 2 quarters · filed 2017-03-01 | $1.17M derived: sum of 3 quarters · filed 2017-03-01 | $1.42M derived: sum of 4 quarters · filed 2017-03-01 |
| 2014-12-31 | $1.86M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $1.64M derived: sum of 2 quarters · filed 2017-03-01 | $1.89M derived: sum of 3 quarters · filed 2017-03-01 | $1.96M 10-K · filed 2017-03-01 |
| 2014-09-30 | -$222.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | $28.00K derived: sum of 2 quarters · filed 2015-11-05 | $104.00K 10-Q · filed 2015-11-05 | $458.00K derived: sum of 4 quarters · filed 2016-03-14 |
| 2014-06-30 | $250.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-13 | $326.00K 10-Q · filed 2015-08-13 | $680.00K derived: sum of 3 quarters · filed 2016-03-14 | $470.00K derived: sum of 4 quarters · filed 2016-03-14 |
| 2014-03-31 | $76.00K 10-Q · filed 2015-05-15 | $430.00K derived: sum of 2 quarters · filed 2016-03-14 | $220.00K derived: sum of 3 quarters · filed 2016-03-14 | $771.00K derived: sum of 4 quarters · filed 2016-03-14 |
| 2013-12-31 | $354.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-14 | $144.00K derived: sum of 2 quarters · filed 2016-03-14 | $695.00K derived: sum of 3 quarters · filed 2016-03-14 | $683.00K 10-K · filed 2016-03-14 |
| 2013-09-30 | -$210.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-13 | $341.00K derived: sum of 2 quarters · filed 2014-11-13 | $329.00K 10-Q · filed 2014-11-13 | $412.00K derived: sum of 4 quarters · filed 2015-03-25 |
| 2013-06-30 | $551.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-14 | $539.00K 10-Q · filed 2014-08-14 | $622.00K derived: sum of 3 quarters · filed 2015-03-25 | |
| 2013-03-31 | -$12.00K 10-Q · filed 2014-05-09 | $71.00K derived: sum of 2 quarters · filed 2015-03-25 | ||
| 2012-12-31 | $83.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-25 | $565.00K 10-K · filed 2015-03-25 | ||
| 2012-09-30 | $482.00K 10-Q · filed 2013-11-25 | |||
| 2011-12-31 | $463.00K 10-K · filed 2014-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B |